Global Exporter & Bulk Supplier: Letrolieva 2.5mg Tablet
🌍 Market Overview
Are you looking to optimize your commercial procurement with a dependable, verified international partner for targeted endocrine therapies? Ernest Oncology (the premier specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd.) is a leading global exporter, wholesale bulk supplier, and distributor of Letrolieva 2.5mg Tablets.
Utilizing our fully compliant international pharmaceutical logistics network, we execute efficient, high-capacity export operations to supply Letrozole 2.5mg directly to global hospital groups, specialized oncology clinics, international pharmacy purchasing groups, and healthcare tender boards across the USA, UK, Australia, and South Africa.
🔬 Product Profile: Letrolieva 2.5mg Tablet
Letrolieva 2.5mg contains Letrozole, a highly potent and selective non-steroidal aromatase inhibitor. It serves as a vital first-line and adjuvant therapeutic option in endocrine-based oncology, specifically formulated to target hormone-dependent malignant pathways in postmenopausal patients.
Active Ingredient: Letrozole (2.5mg)
Therapeutic Class: Antineoplastic / Non-Steroidal Aromatase Inhibitor (AI)
Mechanism of Action: In postmenopausal women, circulating estrogen is synthesized primarily via the conversion of adrenal androgens into estrone and estradiol, catalyzed by the aromatase enzyme complex in peripheral tissues. Letrolieva 2.5mg works by selectively binding to and inhibiting the aromatase enzyme. This targeted action drastically reduces systemic estrogen levels, starving estrogen receptor-positive (ER+) breast cancer cells of the primary signaling hormone they require to survive, proliferate, and spread.
Primary Clinical Indications:
Adjuvant Treatment of Early Breast Cancer: Prescribed as an effective adjuvant therapy for postmenopausal women diagnosed with early-stage, hormone receptor-positive breast cancer to significantly reduce the risk of systemic recurrence.
Extended Adjuvant Therapy: Indicated for postmenopausal women with early-stage breast cancer who have previously completed 5 years of standard sequential tamoxifen therapy.
First-Line / Advanced Treatment: Deployed as an initial systemic intervention for postmenopausal women with locally advanced or metastatic hormone receptor-positive or hormone receptor-unknown breast cancer.
Administration Protocol: To maintain stable therapeutic plasma levels, the tablet should be swallowed whole with water once daily, consistently at the same time each day, with or without food.
📦 Logistics & Sourcing Capabilities
Compliant Supply Lines: Sourced directly through fully validated and legal pharmaceutical manufacturing lines operating under strict global Good Manufacturing Practice (GMP) benchmarks.
Streamlined International Export: Specialized global logistics protocols engineered to navigate strict customs clearances, climate-controlled shipping lanes, and individual regulatory import frameworks within the USA, UK, Australia, and South Africa.
Institutional Sourcing Power: Fully equipped commercial infrastructure ready to fulfill high-volume wholesale requirements, long-term clinical contracts, and competitive public or private medical tenders.
B2B Documentation Suite: Every shipping batch is accompanied by comprehensive commercial documentation, including verified Certificates of Analysis (COA), detailed export invoice clearances, and end-to-end batch tracking.
PRESCRIPTION MEDICINE IS: YES
Disclaimer
Letrolieva 2.5mg Tablet is a highly potent prescription endocrine-targeted medication. It must strictly be administered under the direct guidance, authorization, and ongoing medical supervision of a registered clinical oncologist. This informational profile is structured exclusively for international B2B trade, professional procurement officers, and global commercial pharmaceutical distribution networks; it does not constitute or replace professional medical advice.
📞 Contact Ernest Oncology — Global Medicine Exporter
[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]
🌐 Websites:
📧 Email: exports@ernestpharmaceuticals.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 93599 02383
🔗 WhatsApp Direct Link:https://wa.me/919359902383
